Beta cells from nondiabetic mice transfer secretory vesicles to phagocytic cells. The passage was shown in culture studies where the transfer was probed with CD4 T cells reactive to insulin peptides. Two sets of vesicles were transferred, one containing insulin and another containing catabolites of insulin. The passage required live beta cells in a close cell contact interaction with the phagocytes. It was increased by high glucose concentration and required mobilization of intracellular Ca 2+
Contributed by Emil R. Unanue, August 13, 2015 (sent for review July 6, 2015) Beta cells from nondiabetic mice transfer secretory vesicles to phagocytic cells. The passage was shown in culture studies where the transfer was probed with CD4 T cells reactive to insulin peptides. Two sets of vesicles were transferred, one containing insulin and another containing catabolites of insulin. The passage required live beta cells in a close cell contact interaction with the phagocytes. It was increased by high glucose concentration and required mobilization of intracellular Ca 2+ . Live images of beta cell-phagocyte interactions documented the intimacy of the membrane contact and the passage of the granules. The passage was found in beta cells isolated from islets of young nonobese diabetic (NOD) mice and nondiabetic mice as well as from nondiabetic humans. Ultrastructural analysis showed intraislet phagocytes containing vesicles having the distinct morphology of dense-core granules. These findings document a process whereby the contents of secretory granules become available to the immune system. autoimmune diabetes | autoimmunity | insulin reactivity |
insulin-reactive T cells
A n important issue in understanding the initiation of the autoimmune diabetic process is the manner in which the products of the secretory granule, in particular insulin, are handled by the immune system and made available to the autoreactive T cells. Autoreactivity to insulin is evident in type 1 diabetics and is a major component of the spontaneous diabetes of the NOD mouse (reviewed in refs. 1, 2). In the nonobese diabetic (NOD) mouse, CD4 T cells recognizing insulin peptides are found among the T cells that infiltrate the islets of Langerhans early in the autoimmune process. Such T cells induce disease when isolated and injected into nondiabetic mice (3) (4) (5) . Altogether, a persuasive case has been made for insulin autoreactivity as driving forward diabetic autoimmunity (6) (7) (8) (9) (10) . Our previous investigations showed that the islets of Langerhans of NOD mice contained resident phagocytes represented by two lineages: typical macrophages composed the majority, whereas a minority was made up of a subset of dendritic cells (DCs) expressing the CD103 integrinthat is, the CD103 +
/CD8α
+ DC lineage under the control of the Batf3 transcription factor (11) . Islet phagocytes were found to be in intimate contact with both beta cells and the vessel walls, throwing small projections into the vessel lumen (12) . Importantly, when isolated they were strong antigen-presenting cells (APCs), particularly of insulin epitopes (5, 13) . Furthermore, an initial ultrastructural analysis showed dense-core secretory granules inside vacuoles of the islet phagocytes residing in the islets (13) , and by immunofluorescence islet phagocytes were shown to contain products from the beta cells (5, 13, 14) . Direct evidence of insulin peptides within the beta cells and in islet phagocytes was obtained using a monoclonal antibody that was exclusively reactive with an insulin B chain peptide segment and not with native insulin (5) . The passage of insulin to APCs took place even in nondiabetic mice; for a telling example, it was evident in NOD.Rag1 −/− mice that have no lymphocytes and do not develop diabetes. In brief, inflammation was not a requisite for the acquisition of secretory granule antigens by the APCs. [A structural study in active diabetic rats also showed granules inside monocyte-like cells (15) .] In toto, these results indicated that the products of the secretory granule had been passed to the APCs in vivo. These findings point to a scenario in which beta cells donate the antigenic epitopes that trigger autoreactive T cells to the local phagocytes as an initial stage before the sensitization of the draining pancreatic node (16-21; as reviewed in ref. 22 ).
This study further characterizes the interactions between beta cells and APCs probing with CD4 T cells to insulin. It examines the conditions that generate the insulin peptides recognized by diverse CD4 T cells and documents the passage of vesicles containing the peptides to APCs in a contact reaction dependent on live beta cells. Importantly, it documents that such peptides are also generated from human beta cells, further highlighting the importance of insulin immunoreactivity in T1D.
Results and Discussion
A Functional Assay to Examine the Passage of Insulin Epitopes to Phagocytes. We previously characterized two distinct sets of insulin-reactive CD4 T cells (5, 8, 23) . One set recognizes a peptide resulting from insulin processing by APCs and encompasses residues 13-21 of the B chain. In NOD diabetes, these T cells are poorly represented, most likely because of thymic deletional effects. We have referred to them as "type A," represented here by the IIT-3 clone. The second set recognizes primarily the 12-20 segment of the insulin B chain, a one-amino acid shift of the binding register. This peptide is not expressed after the processing of insulin by APCs but is found when APCs react with denatured insulin or insulin peptides. These clones are relatively abundant in NOD diabetes. We have referred to these T cells as "type B," herein represented by the 8F10 clone. Therefore, comparing the response of these two T cells is useful, in that the T cells directed to
Significance
This report documents that beta cells from islets of Langerhans normally transfer some of their secretory granules to resident phagocytes. The transfer involves a close contact interaction between live beta cells and phagocytes, increases upon glucose stimulation, and requires mobilization of intracellular Ca ++ . In autoimmune diabetes, the CD4 T cells to various peptides of the insulin B chain recognize the transferred antigens in the phagocytes represented in islets by macrophages and a subset of dendritic cells. We have identified a process whereby antigens become available for recognition by autoreactive T cells in type 1 diabetes. the 12-20 segment probe the presentation of denatured insulin or the insulin catabolites but not the native insulin molecule.
In an initial report, we had stained whole isolated islets with antibodies to insulin and also to the insulin B:9-23 peptide (5). The antibody to B:9-23 identified positive granules in beta cells that were larger than the insulin + granules and stained positive with anti-Lamp2 antibodies, suggesting that B:9-23 granules may compose a distinct pool of granules (figure 3 in ref. 5 ). The intraislet APCs contained B:9-23-positive granules at an average of about 10 per cell. To quantitate our previous findings using flow cytometry, islet cells were isolated and examined using antibodies to insulin and the B:9-23 peptide (5). We found insulin and B:9-23 reactivity both in beta cells (Fig. 1A) and in CD45
+

CD11c
+ F4/80 + macrophages (Fig. 1B) , importantly from islets of nondiabetic NOD.Rag1 −/− mice. Similar results were found in islets from 4-6-wk-old NOD mice or C57BL/6 mice. In a different manipulation, beta cells were isolated from NOD.Rag1 −/− mice and subjected to subcellular fractionation of the secretory granules using differential centrifugation of vesicles (24, 25) . The granules were then added to CD11c + DCs isolated from FMSlike tyrosine kinase 3 ligand (FLT-3L)-treated mice, and presentation to the two T cells was examined. (The DCs comprised two sets, a SIRPα+ and a CD24+; the two phagocytes in the islets are a macrophage-SIRPα+ and the CD103+DC. In this report, we do not differentiate between the two sets.) The 25,000 × g fraction that contains the mature secretory granules stimulated the IIT-3 T cells that recognized insulin epitopes and had a much smaller reactivity to 8F10 that only recognizes peptides or denatured insulin. The reverse was found for the 5,000 × g fraction that stimulated strongly the 8F10 (Fig. 1C) . In sum, beta cells contain vesicles that are immunoreactive to B chain-specific antibody; the intraislet APCs likewise show positive reactivity with both B chain peptide as well as insulin-specific antibodies. A culture assay was developed to examine the transfer of insulin immunogenic material from beta cells to phagocytes. Endocrine cells harvested from isolated islets were placed in culture in different media from short time periods of 1-3 h to overnight, after which DCs were added for several hours. (We refer to the endocrine cells as beta cells, as we are probing only insulin transfer.) Lastly, the presence in the DCs of the peptide bound to the I-A g7 class II MHC molecule was probed using either of the two insulin-reactive CD4 T cells.
Testing Beta Cells from Multiple Sources. Fig. 1D shows the specificity of the T cells used in these experiments: The CD4 T-cell 8F10 only recognizes the 12-20 insulin peptide and not the peptide resulting from insulin processing, whereas IIT-3 recognizes the segment 13-21 derived from either insulin processing or free peptide. Knowing the specificity of our T cells as antigenic probes, we sampled their response following beta cell-DC interaction. Beta cells were obtained from NOD.Rag1
−/− mice that do not develop diabetes. As expected, in the absence of additional DCs, the T cells never responded to beta cells, because they lack expression of MHC-II molecules (Fig. 1E) .
Consistently, the addition of DCs after the first 24 h of culture of beta cells in media containing 5 mM glucose resulted in a variable low level of presentation (low glucose in the figures).
(Identical results were also found with 2.5 mM glucose in the media.) Both T cells reacted on average about 10-fold higher over the background stimulation ( Fig. 1 E and F) . Culturing beta cells with 25 mM glucose resulted in a significant increase in insulin presentation by DCs. The response of 8F10 (i.e., to B:12-20 peptide) increased by 352% (n = 13 experiments); with IIT-3 (i.e., to B:13-21 peptide), there was a similar increase (351%, n = 8 experiments) ( The presentation of insulin peptides, as expected, depended on the interaction with class II MHC molecules and was inhibited by addition of a blocking monoclonal antibody to the I-A g7 protein (Fig. 1G) . The specificity of the insulin reactivity was shown by testing islets from mice that express only insulin-2 with a mutation at Tyr-16 of the beta chain (6) . This is a nonimmunogenic insulin known to be nonreactive with either type A or type B T cells (6) (7) (8) 23) ; their beta cells did not elicit a positive response. (The results were as follows. The mean cpm response of T cells alone, T cells plus beta cells and DCs, and the control of beta cells plus DCs plus B:9-23 peptides were for 8F10, 58, 47, and 38,610, respectively, and for IIT-3, 35, 46, and 41,491, respectively.) C57BL/6 mice do not develop spontaneous diabetes. Their beta cells incubated with DCs from NOD mice transferred the immunogenic peptides under low glucose media, whereas the transfer was potentiated by incubating them in high glucose media (Fig.  1H ). In brief, there was no difference in the generation of peptides between beta cells of a different MHC haplotype or diabetessusceptible status. The same transfer took place testing human islet preparations obtained from two recently deceased nondiabetic patients. The segment of the insulin B chain that stimulates the murine 12-20-and 13-21-reactive CD4 T cells is identical between human and mouse (Fig. 1D ). As expected, in both situations, the DCs and the CD4 T cells were from NOD mice-that is, syngeneic-based on MHC restriction rules. Clearly two events are taking place: One is the transfer of the antigenic material from the beta cells, and the second is the DC-T cell interaction, the latter requiring the diabetes-susceptible MHC molecule.
Presentation required the processing of the granules by the DCs. DCs were pretreated with chloroquine, the drug was washed after 1 h, and then the DCs were added to the culture for a short period (because the effects of the drug are reversible). There was significant inhibition by the chloroquine pretreatment, indicating that the insulin vesicle had to be taken to acidic compartments of the phagocyte in order for their contents to be presented to the T cells (Fig. 2C) . The control manipulations testing APCs pulsed with insulin proteins or peptides established, as expected, that presentation of the free peptide was not affected by chloroquine, whereas the presentation of insulin was completely inhibited (Fig. 2D) . Presentation of the peptide-MHC complex from the transferred vesicles, however, was short. Following a 1-h period of incubation of beta cells with DCs, the DCs were separated and T cells were added at various times. There was a progressive drop in presentation so that by 1-2 h there was a 50-75% decrease in the response (Fig. 2E) . In sum, the transfer granules need to enter an acidic compartment of the APCs to release their contents of insulin or insulin peptide, but their time available for immune recognition is relatively short.
The previous findings indicate a close membrane-to-membrane interaction between beta cells and phagocytes that results in the transfer of the granules containing insulin or insulin products. We therefore investigated the potential role of Ca 2+ in the mobilization of granules. We first examined if thapsigargin, a well-established inhibitor of the sarco/endoplasmic reticulum (ER) Ca 2+ ATPase, may modulate the transfer of the granules. Antigen presentation was significantly increased by thapsigargin treatment of beta cells in low glucose media and was further enhanced in high glucose media (Fig. 3A) . [In 10 different experiments, addition of thapsigargin increased by 211% over that of high glucose media (Fig. 3A) .]
Both thapsigargin and high glucose increase cytoplasmic Ca 2+ levels by depleting ER Ca 2+ (26) , raising the possibility that Ca 2+ leakage from the ER, not the Ca 2+ influx from the extracellular space, increases the transfer of granules. To test this idea, the assay was changed to study the requirements for extracellular or intracellular Ca
2+
. Beta cells were incubated with DCs for a limited time of 1 h, after which the DCs were separated from the beta cells: The content of immunoreactive insulin was then probed on the isolated DCs with the T cells. At 5 mM glucose concentration, the transfer was not affected by the absence of extracellular Ca 2+ (n = 4). At 25 mM glucose, the transfer was inhibited by about 25% (n = 9) (Fig. 3B) . In contrast, chelation of intracellular Ca 2+ using 1,2-Bis(2-aminophenoxy)ethane-N,N,N′,N′-tetraacetic acid tetrakis(acetoxymethyl ester) (BAPTA) resulted in complete inhibition, either at low or high glucose concentrations (Fig. 3 C and  D) . The effect of BAPTA chelation was on the beta cells. The isolated DCs were removed and then pulsed with insulin presented to the T cells. This meant that had insulin been transferred in the beta cells and DCs plus BAPTA culture, it would have been presented when the DCs were separated. This conclusion was confirmed in the imaging experiments described below. Collectively, these results suggest that the transfer of granules required an increase in intracellular Ca 2+ levels caused by ER Ca 2+ depletion. ER Ca 2+ depletion is known to induce ER stress and activate the unfolded protein response. We therefore considered the possibility that the unfolded protein response may be involved in the transfer of granules. In our culture assay, during the several hours of culture of DCs with beta cells, we did not find up-regulation in the expression of any of the ER stress sensors: We evaluated a panel of canonical ER stress markers that are highly transcriptionally up-regulated during ER stress responses (27, 28) (Fig. S1 shows one representative result) . In data not presented, the addition to the culture of tunicamycin, a drug known to increase the ER stress response, did not enhance presentation of insulin epitopes to T cells. (In unrelated experiments, the addition to beta cells of each of four cytokines-IFN-alpha A, IFN-gamma, tumor necrosis factor, and interleukin-1 betahad no effect on the transfer to either of the two CD4 T cells.)
Live Imaging of Beta Cells and APCs and Electron Microscopy Examination
of Islets. The passage of granules was also documented by live images of the insulinoma line NIT expressing granules bearing ZnT8 bound to green fluorescent protein (GFP) (29) . We had reported in a previous study on interactions between the insulinoma cell line NIT with DCs and T cells directed to ZnT8 the islet-specific membrane transport for Zn ions (29) . DCs were labeled with CellTrace Violet (false colored red) and added to NIT-ZnT8-GFP cells. Images showed the DCs contacting the NIT: There was a striking and progressive enrichment of GFP + granules to the contact area ( Fig.  4A and Movie S1) in a synapse-like structure. After a contact period, some of the GFP + granules appeared in the DCs, which eventually detached from the beta cells. The time of contact ranged between 20 and 30 min. Such images were found invariably in all DC-NIT interactions. A 3D reconstruction shown in Fig. S2 documents the contact area and passage of the granules to the DCs. DCs were examined after contact with NIT-ZnT8-GFP treated with BAPTA. There were few granules in the contact area and limited transfer of them into the DCs (Fig. 4A, Movie S2, and Fig. S2 ). The contact time in the NIT treated with BAPTA was considerably shorter-just a few minutes. These results paralleled those made in the transfer assay described above ( Fig. 1 E and F) . A similar image of granule transfer was made in the single experiment done with bone marrowderived macrophages (Movie S3).
Islets from young NOD mice including those from NOD.Rag1
−/− mice were examined by electron microscopy. The intraislet phagocytes were found in close contact with beta cells and always next to blood vessels (Fig. 4B) . All of the phagocytes had cytoplasmic vesicles, many of which contained material identical to beta cell secretory vesicles-that is, with a central electron-dense material, a light surrounding the zone, and a thin membrane; others had vesicles with irregular electron-dense material (Fig. 4C) . The structural features indicate that the entire secretory vesicles from beta cells have been taken into the phagocytes. Fig. 4 B and C is from an NOD 8 wk of age; Fig. 4 D and E is from 14-wk-old NOD.
Summary. We show here that beta cells pass the contents of their secretory granules to phagocytes. The presentation assays indicated that the passage involved close interaction between live cells that took place under conditions of low glucose. The passage increased by addition of a high glucose concentration or the drug thapsigargin, both of which increase cytosolic Ca 2+ . The passage took place even in beta cells from mice not undergoing an immunological intervention such as those from NOD.Rag1 −/− mice or C57BL/6 mice; it also took place with human islets obtained from nondiabetic subjects. The passage of granules and/or insulin antigens to phagocytes was also documented in vivo by ultrastructural analysis and by live imaging of beta cells and islet APCs (Fig. 4) (13,14) . In toto, these findings point to a scenario in which secretory granules are being transferred in a constitutive process to the islet resident phagocytes.
The biological relevance of the beta cell-phagocyte interaction outside the context of an autoimmune reaction needs to be evaluated because it may be key in maintaining islet homeostasis. Secretory granules contain a number of bioactive molecules that could well modulate the biology of the phagocytes; phagocytes including tissue macrophages are known to release cytokines and chemokines. In the absence of macrophages, islets are of much smaller size, suggesting a trophic effect of macrophages on islets (12, 30, 31) . We envision a symbiotic interaction between both cells: Experiments in progress indicate that islet macrophages are in an activated state (11, 31) .
The nature of the passage of vesicles during the beta cell-APC interaction is of particular interest. In contrast to the release of insulin granule content taking place under glucose-regulated secretion, the passage involved the whole secretory granule, as was evident from three different results. The ultrastructural analysis showed images compatible with intact granules inside the phagocytes, without any evidence of death of beta cells or inflammation within the islets. The imaging studies pointed to a flow of ZnT8-GFP + granules to areas of contact with the APCs and a rapid flow of the granules into them. The immunological assays probing with the T cells to insulin required a chloroquine-sensitive stage in the APCs, indicating a catabolic process required to release the granule contents. Had free denatured insulin or B chain peptides passed to the APCs, there would not have been a requirement for a chloroquine-sensitive step (Fig. 2C ). This finding is made more evident by the reactivity of the 8F10 T cell that recognizes catabolites of the insulin B chain. APCs that take up soluble denatured insulin or B chain peptide do not require intracellular catabolism, as is well established for diverse protein antigens. These findings are pointing thus to a close membrane interaction between the intraislet phagocytes that stimulated the movement of granules and its passage from one cell to another.
A number of the vesicles passed to the APCs must have contained insulin catabolites, some in the form of denatured insulin chains or peptides from the insulin B chain. We base this conclusion on the fact that we probed with a T cell that recognizes only insulin B chain catabolites offered exogenously to an APC. This T cell does not react with insulin epitopes after the processing of insulin by an APC (5, 6) (Fig. 1D) . Moreover, the monoclonal antibody to insulin B chain peptide identified positive material inside the beta cell as well as in the islet APC. The importance of this finding is that the antibody exclusively reacts with the B chain peptide and not with native insulin, indicating that some intracellular vesicles contain degradative products of insulin. Extensive studies have unequivocally shown that beta cells contain vesicles bearing insulin catabolites, in a pathway referred to as crinophagy (32) (33) (34) (35) (36) . It indicates an intracellular degradation of excess insulin granules, as a mode of controlling the homeostasis of insulin granule content (32, 37) . The impression one obtains from these findings is that the process of generation of the peptidepositive-crinophagic-granules is taking place also constitutively, albeit increased by high glucose. We expect that as active diabetogenesis ensues this process may be modulated, such as a result of the stress conditions that accompanies diabetogenesis (38) (39) (40) . The issue from the perspective of autoimmunity is that the insulin catabolic products constitute the immunogens that select for autoreactive T cells that bypass insulin processing and escape thymus regulation (5, 23) .
We suggest that the findings made here represent the first stage by which immunogenic autoantigens of beta cells are made available to the immune system. We previously reported that insulin-reactive T cells, such as the 8F10 used here, entered islets to contact the intraislet APCs, not requiring a prior activation , either in media prepared without Ca 2+ or media containing 10 μM EGTA-. The results were identical and have been pooled. The T cells were IIT-3; mean cpm at 5 mM glucose was 5,686; at 25 mM, glucose was 11,738. (C and D) Both beta cells and DCs were treated with BAPTA-AM for 1 h, and then the cells were separated. The passage to the DCs was then probed with IIT3. In C and D, cells were in media with 5 mM or 25 mM glucose, respectively. Results are representative of two experiments. In the lower portion of the graph, the DCs were treated with BAPTA for the same time, after which the drug was washed off and insulin was added. The processing of insulin was consistently inhibited by about 30%.
state in pancreatic lymph nodes (23) . Subsequently, presentation of antigens in the pancreatic node represented an active amplification step for diabetogenesis. It is likely that the node is supplied by the movement of islet phagocytes. Recently we reported the seminal role of the CD103
+ DCs in such a process (11) .
Materials and Methods
Islet Isolation, T-Cell Assays. Islets were isolated following standard procedures described before (11) . In brief, collagenase was injected into the pancreas via the common bile duct, after which islets were selected under microscopy with a pipettor. The islet cells were dispersed nonenzymatically and plated in a 12-well tissue culture plate at a density of 2. The following changes in the transfer assay of beta cells-APCs were made. To examine (i) the effects of anti-I-A g7 antibodies, beta cells and DCs were cultured for a day, after which the anti-I-A g7 antibody AG2.42.7 at 10 μg/mL and the T cells were added for another 24 h. To examine (ii) whether the transfer process involves cell-to-cell contact, a transwell system was used in which beta cells and DCs were separated via a 96-well transwell plate containing a 0.4-μm polycarbonate membrane (Corning). In control wells, beta cells were incubated with DCs in the lower chamber of the transwell. To examine (iii) the effects of beta cell viability, the beta cells were cultured with streptozocin (50 mM) first for 12 h before addition of the DCs. To examine (iv) the role of acidification of vesicles in the DCs, the DCs were treated with 100 μM chloroquine (Sigma) for 2 h at 37°C and then collected, washed, and added to the beta cells and the T cells for overnight culture. To examine (v) the effects of extracellular Ca
2+
, beta cells and DCs were incubated in media prepared without any added Ca 2+ ions or in media having 10 μM EGTA for 1 h, after which the DCs were isolated and cultured with the T cells. To examine (vi) the effects of chelation of intracellular Ca 2+ , a culture of beta cells and DCs were treated with 10 μM BAPTA-AM for 1 h, and then the DCs were separated from the beta cells and tested with the T cells. As a control, isolated DCs after the BAPTA treatment were then offered insulin at 10 μM together with the T cells. In steps v and vi, we mostly used the IIT3 line, which is a more sensitive T-cell line. The beta cells (at 10 5 cells) and the DCs (at 6 × 10 5 cells) were incubated in a total volume of 500 μL media. The combined cells were passed through MACS columns, separating the DCs from beta cells.
Microscopy. For electron microscopy, islets were isolated as described above, fixed in Karnovsky fixative, and processed by standard procedures. For live imaging two-photon microscopy, we used the NIT-ZnT8-GFP insulinomas reported before (29) . The cells were cultured in F12 Ham's nutrient mixture (Sigma) supplemented with 10% dialyzed FBS (Sigma), 1.5 g/L sodium bicarbonate, and 2 mM L-glutamine. Before the examination, we replaced the media with CO 2 -independent media (Gibco)/10% FBS. CD11c + DCs were collected from mice injected with FLT-3L as described previously. The DCs were stained with 2 μM Cell Trace Violet (Molecular Probes) for 30 min at 37°C in serum-free CO 2 -independent media. Plated NIT-GFP ZnT8 cells were placed under the two-photon scope. After focusing on the plated cells, DCs were added to the plate. Once DCs appeared in the area, imaging began. We acquired 18-25 z-sections (1.25 μm apart) every minute using a customized SP8 two-photon microscope (Leica) equipped with a 25×/0.95 N.A. water-dipping objective and a Mai Tai HP DeepSee Laser (Spectra-Physics) tuned to 885 nm. Fluorescence emission was separated by high-efficiency custom dichroic mirrors (Semrock) and directed to supersensitive external detectors. CellTrace Violet (Molecular Probes) was detected below 484 nm and GFP between 509 and 562 nm. Image sequences were then processed with Imaris (Bitplane) and Adobe Premiere software. The 3D reconstructions and sectioning were performed with Imaris software (Bitplane). For experiments studying the effects of BAPTA-AM on granule transfer, the above was modified slightly. NIT cell growth media was removed and replaced with fresh growth media containing 10 μM BAPTA-AM. The cells were incubated at 37°C for 2 h. BAPTA containing media was removed from the dish and replaced with fresh growth media for 15 min at 37°C. The DCs were then added as detailed above.
In experiments examining for ERS sensors, total RNA was isolated with Ambion RNAqueous-Micro Kit (Life Technologies). cDNA was obtained from total RNA using First Strand Synthesis Protocol with Reverse Transcriptase (New England BioLabs). TaqMan PCR was performed using TaqMan Fast Universal PCR Master Mix. Primers for quantitative RT-PCR were designed using the PrimeTime predesigned quantitative PCR assays (IDT DNA). PrimeTime primers used 5′-nuclease detection. StepOne 2.1 software was used to perform quality control and the relative expression quantification. We examined an Hsp70 family member (BIP, Hspa5), the ER-calcium regulator Wolfram syndrome 1 protein (Wfs1), the transcription factor C/EBP-homologous protein (CHOP, Ddit3), the activating transcription factor 4 (Atf4), and the growth arrest and DNA damage-inducible protein-34 (GADD34, Ppp1r15a). A is a 3D reconstruction and computational sectioning of DCs at the beginning of synapse formation (Left) and at the point of a mature synapse (Right) (related to Fig. 4 and Movie S1). Green particles increase dramatically inside the DCs during the process of synapse generation (white arrows). B is a quantitation of synapse per DC at 30 min.
